Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 836 studies with search of: | "Preleukemia" |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Terminated |
Study of Lonafarnib Versus Placebo in Subjects With Either Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) (Study P02978AM3)(TERMINATED)
|
||||
2 | Active, not recruiting |
Decitabine in Treating Patients With Myelodysplastic Syndrome
|
||||
3 | Active, not recruiting |
Arsenic Trioxide and Cholecalciferol (Vitamin D) in Treating Patients With Myelodysplastic Syndromes
|
||||
4 | Completed |
Cholecalciferol in Treating Patients With Myelodysplastic Syndrome
|
||||
5 | Recruiting |
Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
|
||||
6 | Active, not recruiting |
Amifostine in Treating Patients With Myelodysplastic Syndrome
|
||||
7 | Active, not recruiting |
Paricalcitol in Treating Patients With Myelodysplastic Syndrome
|
||||
8 | Active, not recruiting |
Biological Therapy in Treating Patients With Myelodysplastic Syndrome
|
||||
9 | Active, not recruiting |
Lenalidomide in Treating Young Patients With Relapsed or Refractory Solid Tumors or Myelodysplastic Syndromes
|
||||
10 | Active, not recruiting |
Interleukin-2 in Treating Patients With Myelodysplastic Syndrome
|
||||
11 | Active, not recruiting |
Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes
|
||||
12 | Completed |
Bryostatin 1 in Treating Patients With Myelodysplastic Syndrome
|
||||
13 | Recruiting |
Vaccine Therapy in Treating Patients With Myelodysplastic Syndromes
|
||||
14 | Completed |
Thalidomide and Epoetin Alfa in Treating Anemia in Patients With Myelodysplastic Syndrome
|
||||
15 | Not yet recruiting |
Everolimus in Treating Patients With Myelodysplastic Syndromes
|
||||
16 | Recruiting |
PXD101 in Treating Patients With Myelodysplastic Syndromes
|
||||
17 | Completed |
Tipifarnib in Treating Patients With Myelodysplastic Syndrome
|
||||
18 | Active, not recruiting |
Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes
|
||||
19 | Suspended |
Azacitidine, Darbepoetin Alfa, and G-CSF in Treating Patients With Myelodysplastic Syndromes
|
||||
20 | Active, not recruiting |
Gemtuzumab Ozogamicin, Fludarabine, and Total-Body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome
|
Previous Page | Studies Shown (1-20) | Next Page (21-40) |